-

The U.S. Healthcare Data Interoperability Market, 2020 - Allscripts, IBM, Change Healthcare, and InterSystems are the Leading Players - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The US Healthcare Data Interoperability Market, 2020" report has been added to ResearchAndMarkets.com's offering.

Interoperability has become a critical consideration for all health IT (HIT) applications. All the major healthcare stakeholders across the world acknowledge the need to invest in digital infrastructure capabilities to facilitate cross-continuum patient information exchanges and support evidence-based care, at scale.

Regulatory agencies are embracing forward-thinking policies that advocate the need for all the leading vendors to become fully interoperable with each other. The objective is to drive a progressive digital healthcare model, that is, a standardized, collaborative, and multidisciplinary yet modular approach that is based on an application programming interface (API).

Many leading HIT vendors and hospitals in the United States are not likely to comply with CMS' 21st Century Cures Act, although it makes provisions for the secure transfer of patient data across the care continuum (due to threats such as breach of patient privacy) and the overwhelming cost of commitment; provisions also exist to cover any significant penalties involved.

Owing to COVID-19, most health systems' essential services (both, manually driven and digitally enabled) are focused on tackling the unprecedented surge in patient footprint across primary, in-patient, and long-term care systems. Therefore, ONC in collaboration with CMS and HHS OIG has extended the timeline for the implementation of Interoperability Final Rules to 3 months post completion of the ONC Health IT Certification Program for specific value-based care tracks.

Allscripts, IBM, Change Healthcare, and InterSystems are the leading US healthcare data interoperability market participants marked on the Research Radar. Optum is the fastest-growing company, and IBM is the most innovative.

Key Topics Covered

1. Strategic Imperative and Growth Environment

  • Strategic Imperative
  • Growth Environment

2. The Research Radar

  • Healthcare Data Interoperability Market 2020
  • Competitive Environment

3. Companies to Action

  • Allscripts Healthcare, LLC
  • Cerner Corporation
  • Change Healthcare
  • Enli Health Intelligence
  • Epic Systems Corporation
  • IBM
  • InterSystems Corporation
  • Lumeon
  • Optum, Inc.
  • Progress Software Corporation
  • Validic

4. Strategic Insights

5. Next Steps: Leveraging the Research Radar to Empower Key Stakeholders

  • Significance of Being on the Research Radar
  • Empowers the CEO's Growth Team
  • Empowers Investors
  • Empowers Customers
  • Empowers the Board of Directors

6. Research Radar Analytics

  • Benchmarking Future Growth Potential

For more information about this report visit https://www.researchandmarkets.com/r/519uq2

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom